A comprehensive evaluation for cognitive impairment should culminate with the communication of the diagnosis to patients and their care partners. Diagnostic disclosure for individuals with cognitive impairment due to Alzheimer’s disease (AD) or AD-related dementias (ADRD) is particularly nuanced and requires a conscientious approach. Clinicians must assess patients’ understanding and appreciation of symptoms, goals for the evaluation, and desire for information. Because AD/ADRD can impact patients’ perceptions of their symptoms, it is recommended to include an informant or care partner for this assessment and for future care. This article provides guidance for addressing the complexities of AD/ADRD diagnostic disclosure to build clinicians’ confidence in communicating diagnostic findings and a plan of care.
Link: Alzheimer’s & Dementia (12/2024)
